Michael John Witty

USPTO Granted Patents = 14 (Patent Applications = 1)

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 61(Granted Patents)

Location History:

Sandwich, GB (1999)
Dover, GB (1985 - 2023)

Company Filing History:

Anacor Pharmaceuticals, Inc.

patents

2 out of 10

Mmv Medicines for Malaria Venture

University of Cape Town

patents

where one patent can have more than one assignee

Years Active: 1985-2023

Loading Chart...

14 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11578087 - Oxaborole esters and uses thereof (2023-02-14),

2. 10882872 - Oxaborole esters and uses thereof (2021-01-05),

3. 10562921 - Oxaborole esters and uses thereof (2020-02-18),

4. 10420772 - Animal and human anti-trypanosomonal and anti-leishmania agents (2019-09-24),

5. 10214495 - Anti-malarial agents (2019-02-26),

6. 10010555 - Animal and human anti-trypanosomonal and anti-leishmania agents (2018-07-03),

7. 9266842 - Anti-malarial agents (2016-02-23),

8. 9024033 - Anti-malarial agents (2015-05-05),

9. 5883080 - Antiparastic auermectin derivatives (1999-03-16),

10. 4927918 - Antiparasitic agents (1990-05-22),

11. 4797490 - Process for the preparation of 3-(2'-fluorophenyl)pyridine (1989-01-10),

12. 4636506 - 7-heterocyclic-1,4-dihydroquinolones (1987-01-13),

13. 4623650 - Antibiotic derivatives of (1986-11-18),

14. 4562197 - Animal growth promotant L-pyroglutamyl-pyridylalanyl-L-prolinamides (1985-12-31),

Title: Michael John Witty: Innovator in Pharmaceutical Solutions

Introduction

Michael John Witty is a renowned inventor based in Dover, Great Britain. With an impressive portfolio of 14 patents, Witty has significantly contributed to the field of pharmaceuticals. His innovative work focuses on developing compounds that address serious health issues, particularly those associated with parasitic diseases.

Latest Patents

Among Witty's latest inventions are the oxaborole ester compounds and their applications. These compounds have shown promise in treating diseases caused by parasites, including Chagas Disease and African Animal Trypanosomosis. His research emphasizes not only the efficacy of these compounds but also their potential to save lives and improve public health on a global scale.

Career Highlights

Witty’s career boasts significant experiences with major pharmaceutical companies, including Pfizer Corporation and Anacor Pharmaceuticals, Inc. At Pfizer, he honed his skills in drug development, enabling him to create impactful treatments. His work has made a notable difference in the pharmaceutical landscape.

Collaborations

Throughout his career, Witty has collaborated with esteemed professionals, including Paul J. Gilligan and Paul R. McGuirk. These partnerships have fueled his innovative spirit and advanced research efforts, leading to successful outcomes in therapeutic development.

Conclusion

In conclusion, Michael John Witty is a prominent figure in the realm of pharmaceutical innovations. With his substantial number of patents and a focus on treating critical diseases, he continues to make significant contributions that benefit societies globally. His work exemplifies the power of innovation in improving health outcomes for those affected by parasitic diseases.

This text is generated by artificial intelligence and may not be accurate.